Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.
Hoffmann MH, Klausen TW, Boegsted M, Larsen SF, Schmitz A, Leinoe EB, Schmiegelow K, Hasle H, Bergmann OJ, Sorensen S, Nyegaard M, Dybkaer K, Johnsen HE.
Hoffmann MH, et al. Among authors: nyegaard m.
Cytometry B Clin Cytom. 2012 May;82(3):123-31. doi: 10.1002/cyto.b.20633. Epub 2012 Feb 10.
Cytometry B Clin Cytom. 2012.
PMID: 22328535
Free article.